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Exposure to an immune challenge in the perinatal period has been
shown to have profound and long-lasting effects on the stress
response throughout later life. Neonatal rats treated with lipopoly-
saccharide (LPS) show a marked increase in sensitivity to stress as
adults compared to their saline-treated counterparts, revealing a
long-term programming of the hypothalamic-pituitary-adrenal
(HPA) axis responses by this early stress (1–3). The mechanism
underlying this effect of LPS is not fully understood, although LPS
administration mimics events occurring during infectious stress,
including the induction of the febrile response, increased produc-
tion of cytokines such as interleukin-1b, interleukin-6 and tumour
necrosis factor-a leading to increased cyclooxygenase-2 and prosta-
glandin-E2 (PGE2) production (4, 5). Nevertheless, neonatal LPS
exposure is associated with increased corticotrophin-releasing fac-
tor (CRF) gene expression in the paraventricular nucleus of the
hypothalamus, and an increase in the pulse frequency and ampli-
tude of corticosterone release in adulthood (1, 6). However, the
critical time period for this neonatal programming is not known.
There has been relatively little research into the interaction of
neonatal immune challenges with the hypothalamic-pituitary-gona-
dal (HPG) axis. Our own study (7) has examined the effects of LPS
administration to neonates on pulsatile luteinising hormone (LH)
secretion and CRF and CRF receptor expression in the medial pre-
optic area (mPOA), and found that an immune challenge on post-
natal days 3 and 5 provokes heightened sensitivity of the
gonadotrophin-releasing hormone (GnRH) pulse generator to the
inhibitory inﬂuence of stress in adulthood. The HPG axis, and hence
the GnRH pulse generator, is now thought to be under the central
control of the kisspeptin (Kiss1) and Kiss1r (otherwise known as
GPR54, the G-coupled receptor for kisspeptin) signalling system in
the hypothalamus. Kisspeptin was established as a potent activator
of the reproductive system via Kiss1r mediation in 2005 (8). This
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Immunological challenge experienced in early life can have long-term programming effects on
the hypothalamic-pituitary-adrenal axis that permanently inﬂuence the stress response. Similarly,
neonatal exposure to immunological stress enhances stress-induced suppression of the hypotha-
lamic-pituitary gonadal (HPG) axis in adulthood, but may also affect earlier development, includ-
ing the timing of puberty. To investigate the timing of the critical window for this programming
of the HPG axis, neonatal female rats were injected with lipopolysaccharide (LPS; 50 lg⁄kg i.p.)
or saline on postnatal days 3 + 5, 7 + 9, or 14 + 16 and monitored for vaginal opening and
ﬁrst vaginal oestrus as markers of puberty. We also investigated the effects of neonatal pro-
gramming on the development of the expression patterns of kisspeptin (Kiss1) and its receptor
(Kiss1r) in hypothalamic sites known to contain kisspeptin-expressing neuronal populations criti-
cal to reproductive function: the medial preoptic area (mPOA) and the arcuate nucleus in neo-
natally-stressed animals. We determined that the critical period for a signiﬁcant delay in
puberty as a result of neonatal LPS exposure is before 7 days of age in the female rat, and
demonstrated that Kiss1, but not Kiss1r mRNA, expression in the mPOA is down-regulated in
pre-pubertal females. These data suggest that the mPOA population of kisspeptin neurones play
a pivotal role in controlling the onset of puberty, and that their function can be affected by
neonatal stress.
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From Molecular to Translational Neurobiologysystem was linked to the function of the HPG axis after it was
noticed that mutations in the Kiss1r gene result in hypogonado-
trophic hypogonadism (9, 10), and that Kiss1r knockout mice exhibit
the same disorder (10). Kisspeptin⁄Kiss1r signalling is considered
part of the hypothalamic circuitry that governs the hypothalamic
secretion of GnRH (11) and is strongly implicated as a ‘gatekeeper’
for the initiation of puberty. Peripheral kisspeptin administration
stimulates precocious puberty in rats (12–14) and sustained gonad-
otrophic hormone secretion in juvenile rhesus monkeys (15). Fur-
thermore, polymorphisms in the Kiss1 gene and activating
mutations in Kiss1r have been associated with precocious puberty
in humans (16, 17). Although the mechanisms controlling the tim-
ing of kisspeptin⁄Kiss1r activation at puberty remain to be estab-
lished, it has recently been shown that 17b-oestradiol (E2)i s
important for driving the increase in hypothalamic kisspeptin
expression prior to puberty in the mouse (18).
Kisspeptin neurones are localised in several nuclei of the hypo-
thalamus. Two of these are crucial for the regulation of gonadotro-
phic hormone secretion in the rat: the mPOA, which includes the
anteroventral periventricular nucleus (AVPV), and the arcuate
nucleus (ARC). During the onset of puberty, Kiss1 and Kiss1r
expression increases in the hypothalamus in both male and female
rats (13); a further study in mice suggests that there is differential
expression of Kiss1 from neurones in the ARC and AVPV during
puberty: the expression shows an increase in the AVPV, but remains
relatively stable in the ARC (19).
In the present study, we tested the hypotheses that a neonatal
immune challenge during a certain critical time window will delay
the onset of puberty, and that such an immune challenge will
affect Kiss1 and Kiss1r expression in the mPOA and ARC nuclei.
Our results suggest that the mPOA population of kisspeptin neuro-
nes may play a pivotal role in controlling the onset of puberty, and
that their function can be affected by neonatal stress.
Materials and methods
Animals
Pregnant Sprague-Dawley rats obtained from Charles River (Margate, UK)
were housed under controlled conditions (12 : 12 h light⁄dark cycle, lights
on 07.00 h; temperature 22  2  C) and supplied with food and water
ad lib. Litters were reduced to a maximum of 14 pups 3 days after birth
(taking the day of birth as day 0), to standardise competition for food and
maternal attention and partially correct for gender imbalance. Litters were
weaned at postnatal (pnd) day 21, and female offspring were housed in
groups of four to six per cage. All procedures were conducted in accordance
with the United Kingdom Home Ofﬁce Regulations.
Neonatal endotoxin exposure: determining a critical
window for delays in puberty as a result of neonatal
immune challenge
Litters were randomly divided into three groups. On pnd 3 and 5, the ﬁrst
group were injected with 50 lg⁄kg endotoxin in 0.05 ml sterile saline (LPS,
serotype Esterichia coli 055:B5; Sigma-Aldrich, Poole, UK), a dose sufﬁcient
to effect permanent HPA axis activation (1, 6). Half the pups in each litter
were designated controls, and received an i.p. injection of sterile saline
(0.05 ml). The second group were injected with LPS (50 lg⁄kg endotoxin in
0.15 ml) or saline on pnd 7 and 9. The third group were injected with LPS
(50 lg⁄kg endotoxin in 0.25 ml) or saline on pnd 14 and 16. Litters were
weaned as described, and females were monitored daily for vaginal opening
from pnd 32. Once vaginal opening occurred, a vaginal smear was taken
using a steel wire loop dipped in sterile saline. Animals were monitored until
ﬁrst oestrus was observed, and weighed weekly.
Neonatal endotoxin exposure: effects on Kiss1 and Kiss1r
expression in the mPOA and ARC
On pnd 3 and 5, a separate group of pups was injected i.p. with 50 lg⁄kg
LPS or saline as control as described above. The animals were killed by
decapitation at various time points: pnd 14, 32, on the day of vaginal
opening (dVO), or pnd 77 (11 weeks of age, hereafter ‘Adult’). Animals from
the latter two groups were monitored for vaginal opening and oestrus
cyclicity as described above, from pnd 32; they were also weighed weekly.
The adult animals were bilaterally ovariectomised at 10 weeks of age and
implanted with a Silastic capsule (inner diameter 1.57 mm; outer diameter
3.18 mm; Sanitech, Havant, UK), ﬁlled to a length of 25 mm with E2
(Sigma-Aldrich) dissolved at a concentration of 20 lg⁄ml arachis oil
(Sigma–Aldrich). The E2-containing capsules were assumed to produced cir-
culating concentrations of E2 within the range observed during the dioe-
strous phase of the oestrous cycle (approximately 38.8  1.2 pg⁄ml) as
previously described by Maeda et al. (20). Surgical procedures were carried
out under ketamine (100 mg⁄kg i.p.; Pharmacia and Upjohn Ltd, Crawley,
UK) and Rompun (10 mg⁄kg i.p.; Bayer, Leverkusen, Germany) anaesthesia.
The rationale for ovariectomy and E2 replacement of the adult group was
to eliminate the impact of a ﬂuctuating gonadal steroid milieu on hypotha-
lamic Kiss1 and Kiss1r mRNA expression and in addition to allow compari-
son with other studies carried out in our laboratory using different stress
paradigms (21).
Tissue collection and quantitative reverse trasncriptase-
polymerase chain reaction (RT-PCR)
Expression of Kiss1 and Kiss1r mRNA was determined by real-time quantita-
tive RT-PCR in the mPOA and ARC from animals culled at pnd 14, pnd 32,
dVO and as adults. The whole brain was carefully removed, frozen on dry
ice, and stored at )80  C. Sections were cut at 300 lm on a cryostat
(Bright Ltd, Cambridgeshire, UK) for RT-PCR. Bilateral punches (1 mm in
diameter) from the mPOA, which included the AVPV, were taken from
bregma +0.2 to )0.4; a single midline punch (1 mm diameter) was taken
from bregma )1.7 to )3.9 to include both ARC nuclei. Co-ordinates were
obtained from the rat brain atlas of Paxinos and Watson (22) using the
micropunch method described by Palkovits (23). The punched sections were
ﬁxed with formalin and stained with crystal violet to conﬁrm correct punch
positioning under a microscope. Total RNA was extracted from the punched
mPOA and ARC tissues for each rat using TRI reagent (Sigma-Aldrich) in
accordance with the manufacturer’s instructions. Reverse transcription was
carried out using the reverse transcriptase Superscript II (Invitrogen, Carls-
bad, CA) and random primer following the manufacturer’s instructions. For
the qPCR, the following primers were used: Kiss1: (sense) 5¢-TGG
CACCTGTGGTGAACCCTGAAC-3¢, (antisense) 5¢-ATCAGGCGACTGCGGGTGGCAC
AC-3¢; Kiss1r: (sense) 5¢-TGTGCAAATTCGTCAACTACATCC-3¢, (antisense) 5¢-AG
CACCGGGGCG GAAACAGCTGC-3¢. 28S rRNA: (sense) 5¢-TTGAAAATCCGGG
GGAGAG-3¢, (antisense) 5¢-ACATTGTTCCAACATGCCAG-3¢. The primer pairs
selected for Kiss1 and Kiss1r detection were designed to amplify across at
least one intron, ruling out the possibility of identical size bands resulting
from genomic DNA ampliﬁcation. Based on the rat Kiss1 genomic sequence
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ment of 192 bp corresponding to nucleotides 74–275 of the GenBank
sequence. The Kiss1r sense primer corresponds to nucleotides 341–533 of
the Genbank sequence (NM023992.1), with cDNA products of 194 bp. The
LightCycler (Roche Biochemicals, Lewes, UK) was used for real-time quanti-
tative analysis of Kiss1 and Kiss1r mRNA expression. The sample cDNA
prepared as above was used as a template for the PCR. During PCR, the
ampliﬁed cDNA products were detected after each annealing phase in real
time using the Faststart DNA Master SYBR Green I kit (Roche Biochemicals).
Each reaction included 2 ll of sample cDNA (optimised so that sample val-
ues of the PCR product were within the standard curve), 0.5 ll each of
25 lM antisense and sense primers, 2 ll1 5m M MgCl2,1ll Faststart DNA
master SYBR Green mix and 4 ll of water to give a total reaction volume
of 10 ll. The Kiss1 reaction conditions were 10 min at 95  C for one cycle,
then 10 s at 95  C, 10 s at 56  C and 10 s at 72  C for 32 cycles. The
Kiss1r reaction conditions were 15 min at 94  C for one cycle, then 15 s at
95  C, 30 s at 63  C and 16 s at 72  C for 34 cycles. The 28S rRNA reaction
conditions were 10 min at 95  C for one cycle, then 15 s at 95  C, 10 s at
54  C and 5 s at 72  C for 28 cycles. Reaction conditions for Kiss1 and
Kiss1r mRNA and 28S rRNA were optimised separately to give the best
results for each primer and for the different quantities of target in samples.
Preliminary experiments were undertaken to optimise the Mg
2+ concentra-
tion, to conﬁrm PCR speciﬁcity by agarose gel electrophoresis and melting
curve analysis, and to prepare the PCR products used to generate standard
curves in real-time PCR. Kiss1 and Kiss1r were quantiﬁed against a standard
curve of samples containing known Kiss1, Kiss1r and 28S PCR product con-
centrations, using the LightCycler
TM software. The 28S rRNA was quantiﬁed
as a reference gene against a separate standard curve of samples containing
known concentrations of 28S rRNA product. The melting curves for Kiss1
and Kiss1r mRNAs and 28S rRNA generated by the LightCycler
TM software
demonstrated that single products were ampliﬁed. PCR product for Kiss1
and Kiss1r mRNAs was sequenced and analysed using an ABI PRISM 310
(Applied Biosystems, Foster City, CA, USA).
Statistical analysis
Comparisons between neonatal LPS and saline treatment groups on vaginal
opening and ﬁrst oestrus were made by subjecting data to one-way ANOVA
and Dunnett’s test. A two-way ANOVA and Newman–Keuls post-hoc analysis
was used to assess the effects of LPS treatment and time on the expression
of hypothalamic Kiss1 and Kiss1r. P < 0.05 was considered statistically sig-
niﬁcant in all cases. Data are presented as the mean  SEM.
Results
Effects of LPS exposure at different time points postnatally
on the timing of pubertal onset
Neonatal administration of LPS on pnd 3 + 5 resulted in a signiﬁ-
cant delay in both the day of vaginal opening (Saline: 39.5  0.4;
LPS: 41.4  0.6; P < 0.05) and day of ﬁrst vaginal oestrus (Saline:
39.4  0.5; LPS: 41.9  0.6; P < 0.05). There were no signiﬁcant
differences between the LPS and saline-treated animals for the pnd
7 + 9 or pnd 14 + 16 animals (P > 0.05), despite a slight trend
towards a delay in the pnd 7 + 9 group (Fig 1). None of the LPS-
treated animals showed signiﬁcant differences in weight compared
to their respective controls (data not shown).
Effects of neonatal LPS exposure on Kiss1 and Kiss1r
expression in the mPOA and ARC across puberty
There was a signiﬁcant decrease in Kiss1 mRNA expression in the
mPOA on pnd 32 (pre-puberty) and adult for animals treated with
LPS neonatally, in comparison to the saline controls. Neither the
pnd 14 nor dVO groups showed a signiﬁcant change in Kiss1 mRNA
expression as a result of neonatal LPS administration. The levels of
Kiss1 mRNA expression differed signiﬁcantly between the pnd 14,
pnd 32 and dVO groups, increasing with age; in both LPS and sal-
ine-treated groups the dVO expression of Kiss1 was signiﬁcantly
higher than in adults (P < 0.05; Fig.2A).
There was no signiﬁcant difference in Kiss1r mRNA expression
across the pubertal transition period, and no signiﬁcant effect from
LPS treatment for pnd 14, pnd 32 or dVO. There was, however, a
signiﬁcant decrease in Kiss1r mRNA expression for the adult ani-
mals in comparison to the dVO group, for both LPS and saline-trea-
ted groups, and a signiﬁcant up-regulation of Kiss1r mRNA
expression in the mPOA in adult animals in response to neonatal
LPS treatment (P < 0.05; Fig. 2B).
In the arcuate nucleus, no signiﬁcant differences in Kiss1 mRNA
expression were observed between the LPS and saline-treated
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Fig. 1. Effects of neonatal lipopolysaccharide (LPS; 50 lg⁄kg i.p.) at postnatal day (pnd) 3 + 5, 7 + 9 or 14 + 16 on the timing of vaginal opening (A) or ﬁrst
vaginal oestrus (B). Data are presented as the delay, in days, in vaginal opening or ﬁrst oestrus due to neonatal-LPS treatment relative to neonatal saline trea-
ted controls. Only the neonatal-LPS treated rats on pnd 3 + 5 showed a signiﬁcant delay in pubertal onset (P < 0.05). (mean  SEM; n = 12–26 per group).
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mRNA expression between the pnd 14 and pnd 32 groups, and
between the pnd 14 and dVO groups, with the expression increas-
ing with age, but no signiﬁcant up-regulation between pnd 32 and
dVO (P > 0.05; Fig. 2C).
Kiss1r mRNA expression in the arcuate nucleus showed no sig-
niﬁcant change either with age or as a result of LPS treatment
(P < 0.05; Fig. 2D). Representative examples of mPOA and ARC
punched brain sections from pnd 77 (Adult) rats are shown in
Fig. 3; the ARC punches shown also contain small extra-arcuate cell
populations including the median eminence. None of the LPS-trea-
ted animals showed signiﬁcant differences in weight compared with
their respective controls (data not shown).
Discussion
The present experiments demonstrate that there is a critical window
for the programming of the developing HPG axis by neonatal
immune challenge with LPS, and that such an insult has a signiﬁ-
cant effect on the timing of puberty and the expression of Kiss1
mRNA in the mPOA during puberty. The effect on pubertal timing
was only signiﬁcant when LPS treatment was given on pnd 3 + 5.
Of note is the absence of effect of neonatal LPS treatment on body
weight (present study, 24), a factor that is well known to affect the
timing of pubertal onset.
There have been few other studies of this phenomenon, although
a recent study by Iwasa et al. (25) reported that, in rats injected
with LPS at postnatal day 10, there was no difference in oestrous
cycle length of adult females between neonatally LPS- and saline-
treated animals, supporting our ﬁndings that an immune challenge
after pnd 7 does not overtly affect reproductive function.
We have shown for the ﬁrst time that neonatal treatment with
LPS on postnatal days 3 + 5 results in a signiﬁcant decrease in
Kiss1 mRNA expression in the mPOA on pnd 32, but no changes in
Kiss1r mRNA expression. This decrease in Kiss1 mRNA expression
could provide a mechanism for the observed delay of puberty. By
contrast, the lack of effect of neonatal LPS treatment on Kiss1 or
Kiss1r expression in the ARC would indicate that kisspeptin⁄Kiss1r
signalling in this brain region is not an obvious contributing factor
to the pubertal delay. The high levels of Kiss1 mRNA in the com-
bined mPOA and ARC of the pnd 32 groups compared to the pnd
14 groups corroborate ﬁndings by Navarro et al. (13) that kisspep-
tin is expressed at a basal level between pnd 10 and pnd 25 in the
whole hypothalamus, and is up-regulated several days before vagi-
nal opening. Navarro et al. (13) observed high expression on pnd
30, which corresponds closely to our chosen time point of pnd 32,
taking into account that we observed vaginal opening on approxi-
mately pnd 38, compared to their pnd 35 for untreated animals. By
contrast to the further marked rise in Kiss1 expression between
pnd 32 and the day of VO in the mPOA, the kisspeptin neurones in
the ARC do not appear to undergo changes during this peripubertal
period.
In the present study, Kiss1r mRNA expression showed no signiﬁ-
cant changes between pnd 14 and pnd 32, unlike the marked
up-regulation of the receptor observed by Navarro et al. (13). This
difference may reﬂect the contrast between analysing speciﬁc brain
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Fig. 2. Effects of neonatal lipopolysaccharide (LPS, 50 lg⁄kg i.p.) or saline control at postnatal day (pnd) 3 + 5 on kisspeptin (Kiss1) mRNA expression in the
medial preoptic area (mPOA) (A) and arcuate nucleus (ARC) (C), and on kisspeptin receptor (Kiss1r) mRNA expression in the mPOA (B) and ARC (D) in female rats
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remains puzzling. Herbison et al. (19) have shown an absence of a
change in Kiss1r expression in preoptic area GnRH neurones during
pubertal development in the male mouse. However, Plant et al. (26)
have reported an increase in Kiss1r mRNA expression across the
pubertal transition in the mediobasal hypothalamus in female rhe-
sus monkeys, although they show no differences in Kiss1r mRNA
expression between juveniles and pubescent males despite an
increase in Kiss1.
Although we have shown very early neonatal exposure to LPS
may delay puberty as a results of long-term changes in Kiss1
mRNA expression in the mPOA, the underlying mechanism of action
of LPS remains to be established. LPS acts to provoke a febrile
immune response through the production of cytokines which stim-
ulate the production of cyclooxygenase-2 and PGE2 (4). PGE2
administration in neonates has been shown to mimic the action of
oestradiol in orchestrating sexually dimorphic neuronal organisation
in the preoptic area, and is linked to masculinisation of sexual
behaviour in female rats (27, 28). Because the LPS administration
on pnd 3 + 5 falls within a critical window during which this sex-
ual dimorphism in the preoptic has been shown to arise (29, 30), it
is possible that there is a link between the action of PGE2 and an
alteration of the normal sexual dimorphism of the kisspeptin neuro-
nes in the AVPV; it has previously been demonstrated that neonatal
androgen administration in the rat plays a role in determining the
sexual dimorphism in the AVPV, but not the ARC (31). It has yet to
be determined whether PGE2 affects the sexually dimorphic organi-
sation of the kisspeptin neurones, but if this is the case, it offers a
possible explanation for the lack of long-term effects on the HPG
axis as a result of LPS treatment on pnd 7 + 9 and 14 + 16
because the timing of these injections may fall outside the (cur-
rently unknown) critical period during which the differentiation
takes place. Further work is required to address these issues.
In adult animals, we found a signiﬁcant increase in mPOA Kiss1r
mRNA expression in response to neonatal LPS administration. This
up-regulation of kisspeptin’s receptor may represent a compensa-
tory effect to allow some reproductive function despite reduced
Kiss1 expression possibly through increased detection of the ligand
by increased receptor presence, although, at the present time, this
is just speculation. Nevertheless, we observed the same down-regu-
lation of Kiss1 and corresponding up-regulation of Kiss1r in
response to both acute and chronic corticosterone administration in
ovariectomised adults, although, in contrast to neonatal LPS treat-
ment, corticosterone signiﬁcantly alters expression proﬁles in both
the mPOA and ARC (21). We have previously shown that adult
animals treated neonatally with LPS exhibit chronic hypercorticoste-
ronaemia, as well as persistent elevation in response to a mild
stressor (6), but neither acute nor chronic stress levels of cortico-
sterone had any effect on pulsatile LH secretion (21). The possible
compensation mechanism for up-regulating Kiss1r in the presence
of low Kiss1 levels in adults would agree with previous reports that,
under nonstressed conditions, pulsatile LH secretion is unaffected
by neonatal treatment with LPS in ovariectomised females (7), sug-
gesting that the altered expression of Kiss1 and its receptor in the
mPOA does not affect the basal operation of the HPG axis, at least
in agonadal female rats. However, we have observed that pnd
3 + 5 LPS treatment has a disruptive effect on oestrus cyclicity,
with many more LPS than saline-treated animals exhibiting irregular
oestrus cycles, both immediately post-puberty and as adults (32),
indicating that the change in Kiss1⁄Kiss1r expression proﬁles as a
result of neonatal LPS may be the ﬁrst manifestation of more long-
lasting changes to the HPG axis, namely the sensitisation to stress-
induced suppression of the GnRH pulse generator in adulthood (7).
The present study is the ﬁrst to demonstrate that a neonatal
immune challenge can have direct effects on the timing of puberty,
concordant with altered hypothalamic Kiss1 expression. That such
an early insult is capable of such long-term effects is not entirely
unexpected. Many studies of perinatal programming (33) have con-
tributed to the understanding that adverse early environments can
have long-lasting effects on adult health, with these changes corre-
sponding to the stages of brain development that continue to
mature both before and after birth. Similar to many epigenetic fac-
tors that inﬂuence development, immunological challenge has come
under scrutiny recently, and neonatal LPS administration has been
discovered to programme a wide range of adult phenotypes, includ-
ing an attenuation of the febrile response (34), insulin sensitivity
(35), susceptibility to stress-induced suppression of reproductive
function (7), and adult anxiety-related behaviour (36). It is apparent
LV
(A)( B)
D3V
1 mm 1 mm
Fig. 3. Representative examples of 300 lm coronal sections of pnd 77 (Adult) rat brain stained with crystal violet, showing the position of the punched med-
ial preoptic area (mPOA) at approximately anteroposterior )0.28 mm from bregma (A) and arcuate nucleus at approximately )4.16 mm from bregma (B). Lat-
eral ventricles (LV) and the dorsal third ventricle (D3V) are also indicated.
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an animal’s immune, metabolic and reproductive functions later in
life; it remains to be shown which changes are adaptations that
allow the animals to better cope with a stressful adult environment,
and which represent disadvantages resulting from disruption at key
points in development.
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